Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Leuk Res. 2010 Aug 4;35(3):329–333. doi: 10.1016/j.leukres.2010.07.017

Table 2. Baseline Characteristics, all patients (n=60).

Age at study entry median in years (IQR) 62.6 (52.7, 69.3)
Disease status refractory 10 (17%)
first relapse 47 (78%)
2 or more relapses 3 (5%)
Prior HiDAC Yes 21 (35%)
no 39 (65%)
Duration of CR1 median in months (IQR) 9.0 (4.0, 13.0)
FAB Classifications n/a 3 (5%)
AML 3 (5%)
M0 5 (8%)
M1 10 (16%)
M2 15 (25%)
M4 14 (23%)
M5B 1 (2%)
M6 3 (5%)
M7 1 (2%)
MDS (RAEB) 2 (3%)
Multilineage 2 (3%)
t-AML 1 (2%)